季俐俐

发布时间:2023-07-25录入员:

姓名:季俐俐

职称:副教授

个人简介:江苏南通人,医学博士。

专业研究领域:基础医学、肿瘤病理、肺癌增殖与耐药研究。

专著与论集:

1.      Ji Lili#*, Moghal Nadeem, Zou Xinru, Fang Yixuan, Hu Shuning, Wang Yuhui, Tsao Ming Sound; The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells, Cancer Med 2022.

2.      Fang Yixuan; Zou Xinru; Hu Shuning; Ji Lili*; Progress of NRF2 Signaling Pathway in Promoting Proliferation of Non-small Cell Lung Cancer, Chinese journal of lung cancer, 2022,25(10): 735-741.

3.      Ji Lili#*; Zhang Rui#; Chen Jie; Xue Qun; Moghal Nadeem; Tsao Ming Sound; PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC, Scientific Reports, 2019, 9: 12437.

4.      Zhang Rui#; Gu Jun#; Chen Jie; Ni Jun; Hung Jieru; Wang Zhiwen; Zhang Xiaochen; Feng Jian*; Ji Lili*; High expression of PINK1 promotes proliferation and chemoresistance of NSCLC, Oncology Reports, 2017, 37(4): 2137-2146.

5.      Wang Shuo#; Chen Yingying#; Li Yupeng; Gu Jun; Gu Shudong; Shi Hai; Li Xuesong; Lu Xiaoning; Li Xiang; Zhang Shuanglong; Yu Kangjun; Liu Kun*; Ji Lili*; DISC1 overexpression promotes non-small cell lung cancer cell proliferation, Oncotarget, 2017, 8(39): 65199-65210.

6.      Chen Jie#; Gu Jun#; Feng Jian; Liu Yifei; Xue Qun; Ni Tingting; Wang Zhiwen; Jia Liangliang; Mao Guoxin*; Ji Lili*; TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-kappaB pathway, Tumor Biology, 2016, 37(3): 3851-3861.

7.      Liu Kun#; Wang Shuo#; Liu Yifei; Gu Jun; Gu Shudong; Xu Zhen; Zhang Rui; Wang Zhiwen; Ma Huaci; Chen Yingying; Ji Lili*; Overexpression of MYCN promotes proliferation of non-small cell lung cancer, Tumor Biology, 2016, 37(9): 12855-12866.

主要科研项目

主持及参与多项科研项目,其中主持的项目包括国家自然科学基金项目1项,江苏省高校面上项目1项、南通市科技计划项目2项。

讲授课程

病理学、

指导研究生情况

已毕业硕士生2名,;在读硕士研究生1名。